Korbel Gregory Alan

CIK 00017890321 companyBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001789032

Recent Transactions

29 trades

Award
Aprea Therapeutics, Inc.$APRE
Common Stock
2022-07-28+24,300→ 45,762 total
Award
Aprea Therapeutics, Inc.$APRE
Stock Option (right to Buy)
2022-07-28+35,700→ 35,700 total
Tax Payment
Aprea Therapeutics, Inc.$APRE
Common Stock
2022-06-03$0.81/sh−8,390→ 21,462 total
Award
Aprea Therapeutics, Inc.$APRE
Stock Option (right to Buy)
2022-03-10+72,600→ 72,600 total
Award
Aprea Therapeutics, Inc.$APRE
Common Stock
2022-03-10+16,000→ 31,841 total
Tax Payment
Aprea Therapeutics, Inc.$APRE
Common Stock
2022-03-10$1.82/sh−1,989→ 29,852 total
Tax Payment
Aprea Therapeutics, Inc.$APRE
Common Stock
2022-02-25$1.74/sh−1,326→ 15,841 total
Exercise/Conversion
Aprea Therapeutics, Inc.$APRE
Common Stock
2021-12-01$0.92/sh+27,500→ 44,667 total
Sale
Aprea Therapeutics, Inc.$APRE
Common Stock
2021-12-01$3.96/sh−27,500→ 17,167 total
Exercise/Conversion
Aprea Therapeutics, Inc.$APRE
Stock Option (right to Buy)
2021-12-01−27,500→ 2,335 total
Sale
Aprea Therapeutics, Inc.$APRE
Common Stock
2021-11-01$5.00/sh−27,500→ 17,167 total
Exercise/Conversion
Aprea Therapeutics, Inc.$APRE
Stock Option (right to Buy)
2021-11-01−2,255→ 29,835 total
Exercise/Conversion
Aprea Therapeutics, Inc.$APRE
Common Stock
2021-11-01$0.92/sh+27,500→ 44,667 total
Exercise/Conversion
Aprea Therapeutics, Inc.$APRE
Stock Option (right to Buy)
2021-11-01−25,245→ 0 total
Sale
Aprea Therapeutics, Inc.$APRE
Common Stock
2021-10-01$4.89/sh−27,500→ 17,167 total
Exercise/Conversion
Aprea Therapeutics, Inc.$APRE
Common Stock
2021-10-01$0.92/sh+27,500→ 44,667 total
Exercise/Conversion
Aprea Therapeutics, Inc.$APRE
Stock Option (right to Buy)
2021-10-01−27,500→ 25,245 total
Exercise/Conversion
Aprea Therapeutics, Inc.$APRE
Common Stock
2021-09-20$0.92/sh+27,500→ 44,667 total
Sale
Aprea Therapeutics, Inc.$APRE
Common Stock
2021-09-20$4.97/sh−27,500→ 17,167 total
Exercise/Conversion
Aprea Therapeutics, Inc.$APRE
Stock Option (right to Buy)
2021-09-20−27,500→ 52,745 total
Sale
Aprea Therapeutics, Inc.$APRE
Common Stock
2021-09-20$4.98/sh−5,460→ 17,167 total
Tax Payment
Aprea Therapeutics, Inc.$APRE
Common Stock
2021-09-10$4.59/sh−1,724→ 22,627 total
Tax Payment
Aprea Therapeutics, Inc.$APRE
Common Stock
2021-08-25$3.98/sh−1,149→ 24,351 total
Award
Aprea Therapeutics, Inc.$APRE
Common Stock
2021-03-10+15,000→ 25,500 total
Award
Aprea Therapeutics, Inc.$APRE
Common Stock
2021-02-25+10,000→ 10,500 total
Award
Aprea Therapeutics, Inc.$APRE
Stock Option (right to Buy)
2021-02-25+41,100→ 41,100 total
Award
Aprea Therapeutics, Inc.$APRE
Stock Option (right to Buy)
2020-03-24+12,800→ 12,800 total
Purchase
Aprea Therapeutics, Inc.$APRE
Common Stock
2019-10-07$15.00/sh+500→ 500 total
Award
Aprea Therapeutics, Inc.$APRE
Stock Option (right to Buy)
2019-10-07+64,322→ 64,322 total

Companies

Aprea Therapeutics, Inc.
VP of Business Dev't
$APRE

Recent Filings

Address

535 BOYLSTON STREET

BOSTON, MA, 02116

View on SEC.gov